Crossref
Understanding recruitment and retention challenges in breast cancer de-escalation of treatment trials
European Journal of Cancer · 2026-03 · 237 · 116336
DOI: 10.1016/j.ejca.2026.116336 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von P. Strach und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Strach, P., Gillies, K., Maclennan, S., Elsberger, B., & MacLennan, S. (2026). Understanding recruitment and retention challenges in breast cancer de-escalation of treatment trials. European Journal of Cancer, 237, 116336. https://doi.org/10.1016/j.ejca.2026.116336
Vancouver
Strach P, Gillies K, Maclennan S, Elsberger B, MacLennan S. Understanding recruitment and retention challenges in breast cancer de-escalation of treatment trials. European Journal of Cancer. 2026;237:116336. doi:10.1016/j.ejca.2026.116336
BibTeX
@article{Strach2026,
author = {Strach, P. and Gillies, K. and Maclennan, S. and Elsberger, B. and MacLennan, S.J.},
title = {Understanding recruitment and retention challenges in breast cancer de-escalation of treatment trials},
journal = {European Journal of Cancer},
year = {2026},
volume = {237},
pages = {116336},
doi = {10.1016/j.ejca.2026.116336}
}
EUVIMED